Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial.

Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial. J Am Heart Assoc. 2018 05 16; 7(11).

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Diabetes Mellitus, Type 2
Dipeptidyl-Peptidase IV Inhibitors
Double-Blind Method
Female
Heart Failure
Humans
Male
Middle Aged
Myocardial Infarction
Piperidines
Recurrence
Risk Assessment
Risk Factors
Stroke
Time Factors
Treatment Outcome
Uracil

authors with profiles

George Bakris